Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Two impurities in finasteride were identified and characterized as cyclohexyl and phenyl analogs.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Trimethoprim-sulfamethoxazole can cause aseptic meningitis.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

Corilagin is the main antitumor component in Phyllanthus niruri, effective against cancer cells.

Tislelizumab can cause cutaneous lupus erythematosus.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.